With a robust background in technology and healthcare investments, the fund manager has executed over 30 deals, demonstrating a strong expertise in identifying high-growth opportunities. Active in North America and Europe, their investment strategy leans towards a data-driven approach, targeting early to growth-stage companies. Notable exits include several successful IPOs and mergers, showcasing a proven track record in generating substantial returns. Emphasizing a thematic investment style, they focus on disruptive innovations that align with evolving market trends.